Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).

about

Synthesis of 3 H, 2 H4 , and 14 C-MK 3814 (preladenant).

P2860

Q38995129-46A76AD9-CBE8-4518-ABF3-842F79BF1572

P2860

Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).

Item

http://www.wikidata.org/entity/Q40750016

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).

@en

type

Item

label

Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).

@en

prefLabel

Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).

@en

P1476

Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).

@en

P2093

D Hesk

http://www.w3.org/2001/XMLSchema#string

D Koharski

http://www.w3.org/2001/XMLSchema#string

K Voronin

http://www.w3.org/2001/XMLSchema#string

P McNamara

http://www.w3.org/2001/XMLSchema#string

S Borges

http://www.w3.org/2001/XMLSchema#string

S Hendershot

http://www.w3.org/2001/XMLSchema#string

S Ren

http://www.w3.org/2001/XMLSchema#string

S Saluja

http://www.w3.org/2001/XMLSchema#string

V Truong

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1

Discovery of 4-[(Z)-(4-bromophenyl)- (ethoxyimino)methyl]-1'-[(2,4-dimethyl-3- pyridinyl)carbonyl]-4'-methyl-1,4'- bipiperidine N-oxide (SCH 351125): an orally bioavailable human CCR5 antagonist for the treatment of HIV infection

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highl

Piperazine-based CCR5 antagonists as HIV-1 inhibitors. II. Discovery of 1-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4- methyl-4-[3(S)-methyl-4-[1(S)-[4-(trifluoromethyl)phenyl]ethyl]-1-piperazinyl]- piperidine N1-oxide (Sch-350634), an orally bioavailabl

Recent progress in discovery of small-molecule CCR5 chemokine receptor ligands as HIV-1 inhibitors.

Highly enantioselective borane reduction of ketones catalyzed by chiral oxazaborolidines. Mechanism and synthetic implications

P304

190-196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JLCR.3387

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26991320

http://www.w3.org/2001/XMLSchema#string

Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).

about

P2860

P2860

Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698